S. . Sleijfer, “Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database”, AO, vol. 57, no. 8, pp. 1117–1126, Aug. 2018.